Fulgent Genetics Inc (FLGT) Q3 2024 Earnings Call Highlights: Strategic Growth Amid Revenue Decline [Yahoo! Finance]
Fulgent Genetics, Inc. (FLGT)
Last fulgent genetics, inc. earnings: 3/10 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.fulgentgenetics.com
Company Research
Source: Yahoo! Finance
GAAP Gross Margin: Non-GAAP Gross Margin: GAAP Operating Expenses: $43.9 million for Q3 2024. Non-GAAP Operating Expenses: $32.9 million for Q3 2024. Non-GAAP Operating Margin: Adjusted EBITDA Income: Approximately $400,000 for Q3 2024. Non-GAAP Income: $9.4 million or $0.31 per share. Cash and Equivalents: Approximately $815.4 million at the end of Q3 2024. 2024 Revenue Guidance: Total core revenue expected to be approximately $280 million. 2024 Non-GAAP Gross Margin Guidance: High 30% range, targeting 40% by year-end. 2024 Non-GAAP EPS Guidance: Improved to a net income of $0.33 per share. Warning! GuruFocus has detected 4 Warning Signs with FLGT. Release Date: November 08, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript Fulgent Genetics Inc ( NASDAQ:FLGT ) reported $71.7 million in total revenue for Q3 2024, driven by momentum in precision diagnostics, particularly in reproductive health and oncol
Show less
Read more
Impact Snapshot
Event Time:
FLGT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FLGT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FLGT alerts
High impacting Fulgent Genetics, Inc. news events
Weekly update
A roundup of the hottest topics
FLGT
News
- With 54% ownership, Fulgent Genetics, Inc. (NASDAQ:FLGT) boasts of strong institutional backing [Yahoo! Finance]Yahoo! Finance
- Fulgent Genetics, Inc. (NASDAQ: FLGT) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.MarketBeat
- All You Need to Know About Fulgent Genetics (FLGT) Rating Upgrade to Strong Buy [Yahoo! Finance]Yahoo! Finance
- Gene Panel Market to Surpass USD 11.75 Billion by 2031 | SkyQuest Technology [Yahoo! Finance]Yahoo! Finance
- Oncology Specimen Provider Reference Medicine Announces Launch of Characterized Specimens, Enabling Increased Speed and Efficiency for Assay DevelopersPR Web
FLGT
Earnings
- 11/8/24 - Beat
FLGT
Sec Filings
- 12/4/24 - Form 4
- 12/4/24 - Form 4
- 12/4/24 - Form 4
- FLGT's page on the SEC website